Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+10.74%+14.81%+51.26%+406.07% 37.23B
+2.55%+2.17%+1.01%+12.92% 21.74B
+3.63%+3.73%-21.30%-40.71% 6.77B
+3.49%+10.11%+4.27%+73.92% 4.57B
+1.50%+1.26%+21.70%+55.44% 2.94B
-1.24%+5.39%+35.24%-26.80% 1.72B
+9.40%+12.62%-30.10%+936.54% 1.89B
-1.19%-2.08%-14.63%-67.45% 1.63B
+0.60%+3.20%+15.11%-6.01% 1.58B
Average +2.94%+3.60%+6.95%+149.33% 8.01B
Weighted average by Cap. +6.43%+7.89%+23.39%+215.11%

Financials

2023 2024
Net sales 346M 4.62M 4.07M 3.75M 3.51M 6.58M 436M 6.7M 45.1M 17.47M 215M 17.35M 16.97M 748M 426M 5.69M 5.01M 4.62M 4.32M 8.09M 536M 8.24M 55.5M 21.5M 264M 21.35M 20.89M 920M
Net income -35.17M -470K -413K -381K -357K -668K -44.26M -681K -4.58M -1.77M -21.83M -1.76M -1.72M -75.96M -13.29M -177K -156K -144K -135K -253K -16.73M -257K -1.73M -671K -8.25M -666K -652K -28.71M
Net Debt - -
Logo GENETICO
TsGRM Genetiko PAO is a Russia-based company primarily engaged in provision of medical services. The Company comprises laboratory and production complexes that provide a range of medical genetic services for both doctors and patients. The Company conducts complex genetic diagnostics of hereditary diseases and reproductive disorders. The Company's structure consists of four laboratories: Next-Generation Sequencing (NGS) laboratory; Non-Invasive Prenatal Testing (NIPT) laboratory; Oncogenetics laboratory; and Genotyping laboratory.
Employees
56
  1. Stock Market
  2. Stocks
  3. GECO Stock